tiprankstipranks
Trending News
More News >
Hepion Pharmaceuticals (HEPA)
:HEPA
US Market

Hepion Pharmaceuticals (HEPA) Financial Statements

Compare
774 Followers

Hepion Pharmaceuticals Financial Overview

Hepion Pharmaceuticals's market cap is currently $3.07M. The company's EPS TTM is $-109.303; its P/E ratio is ―; Hepion Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ -67.13K$ -77.46K$ -86.07K$ -34.52K
Operating Income$ -19.35M$ -48.45M$ -45.49M$ -30.40M$ -20.15M
EBITDA$ -19.35M$ -49.26M$ -43.54M$ -30.32M$ -20.11M
Net Income$ -13.19M$ -48.93M$ -42.20M$ -32.72M$ -20.35M
Balance Sheet
Cash & Short-Term Investments$ 406.41K$ 14.79M$ 51.19M$ 91.35M$ 40.73M
Total Assets$ 1.61M$ 18.09M$ 60.24M$ 103.55M$ 48.65M
Total Debt$ 2.90M$ 209.02K$ 53.61K$ 316.99K$ 752.17K
Net Debt$ 2.49M$ -14.58M$ -51.14M$ -91.03M$ -39.97M
Total Liabilities$ 3.48M$ 10.81M$ 10.39M$ 10.56M$ 8.12M
Stockholders' Equity$ -1.86M$ 7.28M$ 49.86M$ 93.00M$ 40.52M
Cash Flow
Free Cash Flow$ -18.22M$ -40.90M$ -34.98M$ -31.35M$ -16.25M
Operating Cash Flow$ -18.22M$ -40.89M$ -34.96M$ -31.22M$ -16.17M
Investing Cash Flow$ -600.00K$ -14.30K$ -14.07K$ -130.41K$ -85.79K
Financing Cash Flow$ 4.35M$ 4.49M$ -5.14M$ 81.98M$ 43.05M
Currency in USD

Hepion Pharmaceuticals Earnings and Revenue History

Hepion Pharmaceuticals Debt to Assets

Hepion Pharmaceuticals Cash Flow

Hepion Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis